132 related articles for article (PubMed ID: 32485270)
1. Expression of nuclear XIAP associates with cell growth and drug resistance and confers poor prognosis in breast cancer.
Delbue D; Mendonça BS; Robaina MC; Lemos LGT; Lucena PI; Viola JPB; Magalhães LM; Crocamo S; Oliveira CAB; Teixeira FR; Maia RC; Nestal de Moraes G
Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118761. PubMed ID: 32485270
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.
Nestal de Moraes G; Delbue D; Silva KL; Robaina MC; Khongkow P; Gomes AR; Zona S; Crocamo S; Mencalha AL; Magalhães LM; Lam EW; Maia RC
Cell Signal; 2015 Dec; 27(12):2496-505. PubMed ID: 26404623
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
4. Ribosomal protein S3 regulates XIAP expression independently of the NF-κB pathway in breast cancer cells.
Ono H; Iizumi Y; Goi W; Sowa Y; Taguchi T; Sakai T
Oncol Rep; 2017 Nov; 38(5):3205-3210. PubMed ID: 29048653
[TBL] [Abstract][Full Text] [Related]
5. X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma.
Zhang Y; Zhu J; Tang Y; Li F; Zhou H; Peng B; Zhou C; Fu R
Diagn Pathol; 2011 Jun; 6():49. PubMed ID: 21645409
[TBL] [Abstract][Full Text] [Related]
6. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.
Chen J; Gomes AR; Monteiro LJ; Wong SY; Wu LH; Ng TT; Karadedou CT; Millour J; Ip YC; Cheung YN; Sunters A; Chan KY; Lam EW; Khoo US
PLoS One; 2010 Aug; 5(8):e12293. PubMed ID: 20808831
[TBL] [Abstract][Full Text] [Related]
7. Nondegradative ubiquitination of apoptosis inducing factor (AIF) by X-linked inhibitor of apoptosis at a residue critical for AIF-mediated chromatin degradation.
Lewis EM; Wilkinson AS; Davis NY; Horita DA; Wilkinson JC
Biochemistry; 2011 Dec; 50(51):11084-96. PubMed ID: 22103349
[TBL] [Abstract][Full Text] [Related]
8. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation.
Lin MT; Chang CC; Chen ST; Chang HL; Su JL; Chau YP; Kuo ML
J Biol Chem; 2004 Jun; 279(23):24015-23. PubMed ID: 15044484
[TBL] [Abstract][Full Text] [Related]
9. X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression.
Neil JR; Tian M; Schiemann WP
J Biol Chem; 2009 Aug; 284(32):21209-17. PubMed ID: 19531477
[TBL] [Abstract][Full Text] [Related]
10. Survivin Inhibitors Mitigate Chemotherapeutic Resistance in Breast Cancer Cells by Suppressing Genotoxic Nuclear Factor-
Wang W; Zhang B; Mani AM; Wu Z; Fan Y; Li W; Wu ZH
J Pharmacol Exp Ther; 2018 Jul; 366(1):184-193. PubMed ID: 29735611
[TBL] [Abstract][Full Text] [Related]
11. XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype.
Evans MK; Brown MC; Geradts J; Bao X; Robinson TJ; Jolly MK; Vermeulen PB; Palmer GM; Gromeier M; Levine H; Morse MA; Van Laere SJ; Devi GR
Cancer Res; 2018 Apr; 78(7):1726-1738. PubMed ID: 29351901
[TBL] [Abstract][Full Text] [Related]
12. XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation.
Huang X; Wang XN; Yuan XD; Wu WY; Lobie PE; Wu Z
Oncogene; 2019 Feb; 38(9):1448-1460. PubMed ID: 30275562
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression.
Aird KM; Ding X; Baras A; Wei J; Morse MA; Clay T; Lyerly HK; Devi GR
Mol Cancer Ther; 2008 Jan; 7(1):38-47. PubMed ID: 18202008
[TBL] [Abstract][Full Text] [Related]
14. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.
Aird KM; Ghanayem RB; Peplinski S; Lyerly HK; Devi GR
Mol Cancer Ther; 2010 May; 9(5):1432-42. PubMed ID: 20406946
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
16. X-linked inhibitor of apoptosis protein (XIAP) lacking RING domain localizes to the nuclear and promotes cancer cell anchorage-independent growth by targeting the E2F1/Cyclin E axis.
Cao Z; Li X; Li J; Luo W; Huang C; Chen J
Oncotarget; 2014 Aug; 5(16):7126-37. PubMed ID: 25216527
[TBL] [Abstract][Full Text] [Related]
17. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
18. XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.
Hussain AR; Siraj AK; Ahmed M; Bu R; Pratheeshkumar P; Alrashed AM; Qadri Z; Ajarim D; Al-Dayel F; Beg S; Al-Kuraya KS
BMC Cancer; 2017 Sep; 17(1):640. PubMed ID: 28893228
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
20. The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.
Akkiprik M; Hu L; Sahin A; Hao X; Zhang W
BMC Cancer; 2009 Apr; 9():103. PubMed ID: 19341485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
